Corium’s proprietary MicroCor™ produces an array of microstructures that mechanically creates reversible “micro-pores” in the outer skin barrier to facilitate transdermal delivery. The technology is covered by over 50 patents that were acquired from Procter & Gamble. The microstructure array can be fabricated from a variety of materials (including flexible polymers) using a continuous embossing process that allows for reproducible, low cost and high volume production. The microstructure array is integrated into custom designed delivery systems for painless administration of small and large molecular weight molecules through the skin.

Key Benefits:

	Eliminates fear and pain of needles
	Self administration, user friendly
	Delivers proteins, peptides and vaccines through the skin
	Attractive to third party payers
	Broad based acute and chronic therapy
	Significant patent coverage by Corium